Clinical Trial Update: Stopping Tyrosine Kinase Inhibitors in Affecting Treatment-Free Remission in Patients With Chronic Phase Chronic Myeloid Leukemia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating whether stopping tyrosine kinase inhibitors can influence treatment-free remission in patients with chronic myeloid leu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Tyrosine kinase inhibitors

Snippet

Sponsor: Children's Oncology Group | Conditions: Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | Phase 2 | Status: ACTIVE_NOT_RECRUITING